Koyfin Home > Directory > Health Care > Aduro Biotech > EBITDA / Interest Expenses

Aduro Biotech EBITDA / Interest Expenses Chart (ADRO)

Aduro Biotech annual/quarterly EBITDA / Interest Expenses from 2013 to 2014. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Aduro Biotech EBITDA / Interest Expenses for the quarter ending December 12, 2014 was $-52m a 91.48% decrease of -48m year over year
  • Aduro Biotech EBITDA / Interest Expenses for the last 12 months ending September 09, 2015 was $-853m a 99.08% decrease of -845m year over year
  • Aduro Biotech Annual EBITDA / Interest Expenses for 2014 was $-8m a -33.32% increase of 3m from 2013
  • Aduro Biotech Annual EBITDA / Interest Expenses for 2013 was $-11m a -13,479.63% increase of 1,416m from 2012
  • Aduro Biotech Annual EBITDA / Interest Expenses for 2012 was $-1,427m
Other Ratios Metrics:
  • Aduro Biotech Total Debt / Capital for the quarter ending September 09, 2014 was $4m
  • Aduro Biotech Other Liabilities for the quarter ending December 12, 2018 was $192m a 1.13% increase of 2m year over year
  • Aduro Biotech Total Debt / Equity for the quarter ending September 09, 2014 was $4m
View Chart On Koyfin

Quarterly ADRO EBITDA / Interest Expenses Data

12/2014$-52m
09/2014$-176m
06/2014$-7m
03/2014$-4m
12/2013$-5m

Annual ADRO EBITDA / Interest Expenses Data

2014$-8m
2013$-11m
2012$-1,427m